Incrit 50 mg (Tablet)
Unit Price: ৳ 18.05 (2 x 10: ৳ 361.00)
Strip Price: ৳ 180.50
Medicine Details
Category | Details |
---|---|
Generic | Sitagliptin |
Company | Synovia pharma plc |
Also available as |
Indications
- Adjunct to diet and exercise for type 2 diabetes mellitus
- Monotherapy and combination therapy
- Improves glycemic control
- Not for type 1 diabetes
- Not for diabetic ketoacidosis
- Not studied in patients with a history of pancreatitis
Pharmacology
- DPP-4 inhibitor
- Slows inactivation of incretin hormones
- Increases and prolongs action of incretin hormones
- Regulates glucose homeostasis
- Increases insulin release
- Decreases glucagon levels
- Selectivity for DPP-4
Dosage & Administration
- Recommended dose of 50mg twice a day or 100mg once daily
- Can be taken with or without food
Interaction
- Did not alter pharmacokinetics of certain drugs
- Slightly increases digoxin concentration
Contraindications
- History of serious hypersensitivity reaction to sitagliptin
Side Effects
- Common adverse reactions include headache, upper respiratory tract infection, and nasopharyngitis
- Hypoglycemia may occur in patients treated with combination therapy
Pregnancy & Lactation
- Pregnancy Category B
- Should be used during pregnancy only if clearly needed
- Caution should be exercised when administered to a nursing woman
Precautions & Warnings
- Prompt discontinuation if pancreatitis is suspected
- Dosage adjustment in patients with renal insufficiency
- Caution when used with medications known to cause hypoglycemia
- Reports of serious hypersensitivity reactions
- Safety and effectiveness in pediatric patients not established
- Careful dose selection in elderly with decreased renal function
Use in Special Populations
- Safety and effectiveness in pediatric patients under 18 years not established
- Caution and dose adjustments in elderly with decreased renal function
Overdose Effects
- Maximal mean increases in QTc of 8.0 msec observed at high doses
- Usual supportive measures recommended in the event of an overdose
- Modestly dialyzable
Therapeutic Class
- Dipeptidyl Peptidase-4 (DPP-4) inhibitor
Storage Conditions
- Store below 25°C in a dry place away from light
- Keep out of the reach of children
- Do not use after expiry date
- To be dispensed only on prescription of a registered physician